Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Source study found

Story checked

New tool identifies older adults at risk of delirium and falls from anticholinergic medications (opens in a new tab)

news-medical.net · 2026-11-05

Short answerEvidenceSource

Short answer

Not assessed

Check incomplete.

We found a likely source study, but its evidence could not be prepared for claim review. The article's claims remain unverified.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Source study identified.

A source study was identified, but the study's evidence could not be prepared for claim assessment. No claim verdicts are available.

View article claims
3
Then inspect each claim

Evidence layer

Claim by claim

A source study was identified, but the study's evidence could not be prepared for claim assessment. The claims below have not been assessed.

Claim 1 of 5Not checkedResearchers funded by Health Data Research UK developed a new tool to help doctors and pharmacists identify older patients at risk of delirium and serious falls associated with taking multiple anticholinergic medications.View evidenceHide evidence

Not checked

A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.

Claim 2 of 5Not checkedPublished in BMJ Medicine, researchers at the University of Leeds, University of Liverpool and Bradford Institute for Health Research developed the Anticholinergic Medication Index (ACMI) to score a patient's anticholinergic burden, based on the risk of delirium or falls.View evidenceHide evidence

Not checked

A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.

Claim 3 of 5Not checkedThe ACMI was piloted at GP surgeries in Bradford to automatically generate lists of patients aged 65+ with their score, contributing medicines, and one-year predicted risk of fall or delirium for medication review prioritization.View evidenceHide evidence

As statedpatients aged 65+; one-year predicted risk

Not checked

A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.

Claim 4 of 5Not checkedThe ACMI was developed and tested using health data from nearly 750,000 adults aged over 65 years, and it was tested using a national dataset of patients in Wales.View evidenceHide evidence

As statednearly 750,000 adults aged over 65 years

Not checked

A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.

Claim 5 of 5Not checkedA related calculator, ACMICS, is embedded directly within hospital electronic patient record systems at two NHS Trusts and is now live and in use.View evidenceHide evidence

As statedtwo NHS Trusts

Not checked

A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Open the paper in Tessa

Anticholinergic medication index: advancing safer prescribing for older adults

BMJ Medicine · 2026

Source record (opens in a new tab)

Why this one

Confident

NewsLink found the paper. Tessa is where you inspect it deeply.

Papers considered

The selected paper, plus nearby candidates.

Crossref · 37 candidate papers

Candidate

Factors Associated with Developing Cancer Therapy-Related Cardiac Dysfunction Differ by Cancer Diagnosis

Cardiovascular Medicine · 2026 · Crossref

Source (opens in a new tab)
Candidate

P1.273: Real-World Burden of Illness in Patients With Metastatic NSCLC and PD-L1 TPS =50%

Journal of Thoracic Oncology · 2026 · Crossref

Source (opens in a new tab)

And 31 more candidates considered.